From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
F-star Biotechnology Ltd.
HeadquartersCambridge, UK

F-star Biotechnology Ltd. is a biotechnology company, founded in Vienna in 2006,[1] with a current main research site in Cambridge, UK. The company is focused in developing bispecific monoclonal antibodies using a modular combinatorial approach that engineers the Fc constant region of an immunoglobulin into a novel antigen-binding site.[2][3]

See also[edit]

  1. ^ "F-star starts its operations" (PDF). F-Star. 12 June 2006. Retrieved 12 December 2016.
  2. ^ http://www.f-star.com
  3. ^ Wozniak-Knopp G, Bartl S, Bauer A, Mostageer M, Woisetschläger M, Antes B, Ettl K, Kainer M, Weberhofer G, Wiederkum S, Himmler G, Mudde GC, Rüker F (2010). "Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties". Protein Eng Des. 23 (4): 289–297. doi:10.1093/protein/gzq005. PMID 20150180.